wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41091625-E19990C9-88F3-4BA8-B16C-887DDF645CE2
Q41091625-E19990C9-88F3-4BA8-B16C-887DDF645CE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41091625-E19990C9-88F3-4BA8-B16C-887DDF645CE2
Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab.
P2860
Q41091625-E19990C9-88F3-4BA8-B16C-887DDF645CE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41091625-E19990C9-88F3-4BA8-B16C-887DDF645CE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ce982bbdd429719ba1dca04a8899b7a8d086d83
P2860
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.